We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breast Density Notification Laws in the USA Found to Considerably Raise Costs Yet Save Few Lives

By MedImaging International staff writers
Posted on 24 Dec 2014
Laws requiring supplemental ultrasound screening for women with dense breasts would significantly increase costs and save comparatively few lives, according to new research.

The study was conducted by investigators from a number of leading medical institutions worldwide, including the University of Vermont (Burlington, Vermont, USA); Harvard Medical School (Boston, MA, USA); Albert Einstein School of Medicine (Bronx, NY, USA), and Erasmus Medical Center (Rotterdam, the Netherlands). They published their findings online December 9, 2014, in the journal Annals of Internal Medicine.

More than 50% of women between the ages of 40 and 74 have dense breast tissue, which puts them at increased risk for breast cancer and affects how well a mammogram can identify abnormalities. As such, at least 19 US states have enacted breast density notification laws so that women can make informed decisions about supplemental screening, such as ultrasound.

With similar legislation being considered at a national level, researchers sought to determine the benefits, harms, and cost-effectiveness of supplemental ultrasound screening for women with dense breasts. Three validated simulation models predicted that supplemental ultrasound screening after a negative mammogram for women with dense breasts would result in limited health gains and substantially increased expenses.

According to model estimates, supplemental screening for women with dense breasts and a negative mammogram would save 0.36 additional breast cancer deaths, gain 1.7 quality adjusted life years (QALYs), and result in 354 false-positive ultrasound biopsy recommendations per 1,000 women with dense breasts compared to biennial screening by mammography alone. The cost-effectiveness ratio was USD 325,000 per QALY gained, but costs could be improved by restricting supplemental ultrasound screening to women with extremely dense breasts.

Related Links:
University of Vermont 
Harvard Medical School 
Albert Einstein School of Medicine 

Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Ultrasonic Pocket Doppler
SD1
Digital X-Ray Detector Panel
Acuity G4
MRI System
nanoScan MRI 3T/7T

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.